Study: Carotid stents, regardless of origin, are similarly effective at preventing stroke, death

Is one stent better than another? University of Pennsylvania researchers compared three different carotid stents and found they are significantly similar to one another--and also highly effective at preventing stroke and death. As published in the journal JACC: Cardiovascular Interventions, the study explored three different stent-and-embolic-protection-device combinations: Acculink/Accunet and Xact/Emboshield from Abbott ($ABT) and Precise/Angioguard from Cordis. It found that all three are associated with similarly low rates of stroke and death "on the order of 2%" in over 12,000 procedures, according to lead author Jay Giri. "A tremendous amount of time and energy has been spent theorizing about various technical considerations of carotid stenting systems that might make one superior to another," Giri said in a statement. "Our study effectively argues that continued focus on these specific technical aspects is unlikely to significantly improve stroke and death rates around carotid stenting." UPenn report | Abstract

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.